Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 23, 2023, at. | May 25, 2023
Item 1.01 Entry into a Material Definitive Agreement.
The information regarding the Purchase Agreements set forth
in Item 8.01 of this Current Report on Form 8-K is incorporated by reference
into. | May 25, 2023
Item 7.01 Regulation FD Disclosure.
From time to time, Syros Pharmaceuticals, Inc. intends to
conduct meetings with third parties in which its current corporate slide
presentation is presented. A. | May 25, 2023